Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 3460  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Article Submission Resources Sections Etcetera Contact
 
  NAVIGATE Here 
  Search
 
 :: Next article
 :: Previous article 
 :: Table of Contents
  
 RESOURCE Links
 ::  Similar in PUBMED
 ::  Search Pubmed for
 ::  Search in Google Scholar for
 ::Related articles
 ::  Article in PDF (317 KB)
 ::  Citation Manager
 ::  Access Statistics
 ::  Reader Comments
 ::  Email Alert *
 ::  Add to My List *
* Registration required (free) 

  IN THIS Article
 ::  Abstract
 ::  Material and Methods
 ::  Results
 ::  Discussion
 ::  Acknowledgements
 ::  References
 ::  Article Figures
 ::  Article Tables

 Article Access Statistics
    Viewed18346    
    Printed328    
    Emailed15    
    PDF Downloaded407    
    Comments [Add]    
    Cited by others 20    

Recommend this journal


 


 
ORIGINAL ARTICLE
Year : 2004  |  Volume : 50  |  Issue : 1  |  Page : 21-26

Invasive pulmonary aspergillosis: A study of 39 cases at autopsy


1 Department of Pathology (Cardiovascular and Thoracic Division), Seth G. S. Medical College, Mumbai, India, India
2 Department of Pathology, T. N. Medical College, Mumbai, India, India

Correspondence Address:
P Vaideeswar
Department of Pathology (Cardiovascular and Thoracic Division), Seth G. S. Medical College, Mumbai, India
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 15047994

Rights and PermissionsRights and Permissions


 :: Abstract 

Background: Aspergillus is a common cause of invasive mycosis, especially in immunocompromised or immunosuppressed individuals. Aims: To study the incidence of invasive pulmonary aspergillosis and evaluate the predisposing factors and clinico-pathological manifestations. Settings and Design: Retrospective analysis of autopsy material from a tertiary care hospital. Material and Methods: All autopsies performed over a 12-year period were reviewed and cases with invasive aspergillosis were analysed with respect to their clinical presentation, predisposing factors, gross and histological features, complications and causes of death. Results: Among a total of 20475 autopsies performed in 12 years, 39 patients (0.19 %) had invasive pulmonary aspergillosis. There were 28 males and 11 females. Their ages ranged from five months to 67 years. Dyspnoea, fever, cough with mucopurulent expectoration, chest pain and haemoptysis were commonly encountered symptoms. Forty-one per cent of the patients had no respiratory symptoms. Fungal aetiology was not entertained clinically in any of the patients. The major underlying conditions were prolonged antibiotic therapy, steroid therapy, and renal transplantation, often associated with underlying lung diseases. Pneumonia, abscesses, vascular thrombosis and infarction were common findings at autopsy. Antecedent tuberculosis, mucormycosis, Pneumocystis carinii pneumonia and Cytomegalovirus infection were also present. In most cases, death was related to extensive pulmonary involvement or fungal dissemination. Conclusion: A diagnosis of invasive pulmonary aspergillosis should always be borne in mind whenever one is dealing with recalcitrant lung infections even with subtle immunosuppression. Radiological investigations and serologic markers can be utilised for confirmation and prompt therapy.


Keywords: Lung, Aspergillus infection, invasive aspergillosis, immunosuppression


How to cite this article:
Vaideeswar P, Prasad S, Deshpande J R, Pandit S P. Invasive pulmonary aspergillosis: A study of 39 cases at autopsy. J Postgrad Med 2004;50:21-6

How to cite this URL:
Vaideeswar P, Prasad S, Deshpande J R, Pandit S P. Invasive pulmonary aspergillosis: A study of 39 cases at autopsy. J Postgrad Med [serial online] 2004 [cited 2019 Nov 14];50:21-6. Available from: http://www.jpgmonline.com/text.asp?2004/50/1/21/6648


Aspergillus is a common cause of invasive mycosis and the incidence is showing a rising trend following organ transplantation, chemotherapeutic modalities and other causes of immunosuppression. [1] Autopsy data have been few and have stressed the occurrence in haematological disorders, solid organ transplantation and human immunodeficiency virus (HIV) infection.[2],[3],[4] This prompted us to study the incidence of invasive pulmonary aspergillosis (IPA) with respect to the underlying causes and pathological manifestations of the Aspergillus invasion.




 :: Material and Methods Top


This was a retrospective study, conducted in a large tertiary care general hospital that largely caters to the middle and lower socio-economic classes. There is a renal transplant program with an average of 20 to 25 live-related transplants annually; there are no specific oncology services. The incidence of HIV positivity among the admitted patients ranges from 11 to 12%. As per the hospital policy, autopsies are not performed in such patients. The autopsy rate is about 20%. All autopsies performed over a period of 12 years were reviewed and those cases indexed as IPA were analysed. The relevant clinical data was obtained from indoor case sheets in the medical records department, and autopsy records kept in the pathology department. Age, gender, duration of admission, predisposing factors, clinical features, investigations, gross and microscopic features in the lungs and other organs, complications and causes of death were noted. Relevant sections were retrieved and reviewed. All sections were stained with haematoxylin and eosin. Gomori′s methenamine silver was the special stain used to identify the fungal elements.




 :: Results Top




Among a total of 20475 autopsies conducted over 12 years, there were 39 patients with IPA (0.19%), affecting 28 males and 11 females. Their ages ranged from five months to 67 years. Males in the second and third decades of life were commonly affected. Patients were admitted for a period of 15 hours to 33 days. Less than half of the patients were admitted in the intensive respiratory care unit; others were from general medical units with a few from surgical specialities. The chief symptoms were fever, breathlessness, cough with or without mucopurulent sputum, chest pain or haemoptysis. Two patients developed the above symptoms during their stay in the hospital. Sixteen patients (41%) did not have respiratory symptoms.



The main predisposing factors were prolonged antibiotic therapy, steroid therapy and renal transplantation [Table - 1] . Twelve (30.8%) had more than one predisposing factor. Six were in intensive care units for ten or more days, some requiring ventilatory care. Six had no apparent predisposing factor.



Haematological findings were not available in 11 patients. The remaining had anaemia (14), neutrophilia (15), eosinophilia (1), atypical lymphocytosis (1), neutropenia (1), pancytopenia (2) and normal leucocyte counts (6). Chest radiography revealed bronchiectasis in two, unilateral or bilateral opacities in nine, fluffy shadows and cavitary lesions in two cases each and reticulo-nodular shadows in one. Radiological features could not be reviewed in the remaining 22 patients. Fungal aetiology was not suspected clinically in any of these patients. Sputum was positive for Aspergillus species in two patients where sputum and bronchial secretions were sent for routine cytological examination. These were submitted for culture studies. Acid-fast bacilli or Pneumocystis carinii were present in two others. Serology was positive for leptospirosis in two and for Cytomegalovirus in one.



On gross examination of lungs, 17 cases showed patchy to diffuse pleural fibrosis. Film of fibrinous or fibrinopurulent exudate over the visceral pleura was present in 15. Barring four cases, the lungs revealed greyish white to yellow areas of pneumonic consolidation. These were bilateral and multifocal in all except 1 case, where it was restricted to the right upper lobe. Alveoli were filled with polymorphonuclear inflammatory exudate, with break down of the alveolar septa and formation of abscesses (27 cases). The fungal colonies often tended to be confined to the necrotic material and appeared as branching, slender, septate hyphae [Figure - 1]. Gross cavitations were noted in 15 patients that contained grey white semisolid contents.



Another characteristic noted in many lungs was angioinvasion (28 patients), producing bland thrombi (19 cases) and/or acute necrotising arteritis (6 cases, [Figure - 2]. This resulted in two distinct pathologic variants. Twenty-four patients showed subpleural, wedge-shaped foci of haemorrhagic infarction or areas of haemorrhage. In addition, seven patients also showed the so-called target lesions [Figure - 3]. These appeared as fairly well-circumscribed, non-subpleural lesions with pale centres and haemorrhagic borders. The pale areas were composed of coagulative necroses of the lung parenchyma with a tangle of fungal hyphae. Inflammatory reaction was significantly absent. These were bordered by congested or haemorrhagic viable parenchyma. This was the sole finding in one case, a young male operated for rheumatic heart disease with postoperative mediastinitis.



Involvement of the tracheobronchial tree was seen in six patients. Two among these were not associated with pneumonia. One had acute necrotising bronchiolitis. The other, a case of leptospirois on mechanical ventilation, had obliterative shaggy yellowish brown exudate in the bronchi with ulcerative tracheitis [Figure - 4] along with lung infarction. One other case had unusual findings. The patient, a 17-year-old male had paroxysmal episodes of breathlessness since childhood with streaky haemoptysis. The patient had been treated with anti-tuberculous drugs and steroids in the past, with no response to therapy. Diagnostic bronchoscopy was performed. Secretions were aspirated and transbronchial lung biopsy was performed. Septate hyphae were seen in the bronchial secretions. Biopsy showed granulomatous inflammation, in which hyphae could be demonstrated within the giant cells. This was the only patient who received anti-fungal therapy, but expired within 24 hours of the institution of specific therapy. On gross examination, pleurae were markedly thickened with multiple yellow nodules fused to form geographic areas. Cut surfaces revealed accentuation of the lobular septa and bronchovascular bundles with nodular and miliary areas [Figure - 5]. Mediastinal lymph nodes were enlarged and had similar firm yellowish appearance. On microscopy, multiple granulomata [Figure - 6] were seen with colonies of fungal hyphae, involving the airways, parenchyma and vessels and the lymph nodes, an example of granulomatous aspergillosis.



Fibrocavitary tuberculosis was seen in five with aspergilloma and post-tuberculous bronchiectasis in two cases each. Active tuberculosis was present in six. Additional organisms detected in the lung sections were Candida (1 case), Mucor (2 cases), Pneumocystis carinii (2 cases) and Cytomegalovirus (1 case).



Apart from the lungs, other organs also bore the brunt of the aspergillus onslaught in eight patients (20%, [Table - 2]. The chief finding was suppurative cerebritis (62.5%). In addition, multi-organ zygomycosis involving the cerebral hemispheres, transplanted kidney and stomach was seen in three patients. In the majority (46.1%), mortality was related to extensive lung involvement [Table - 3]. Calcium oxalate crystals were identified as irregularly angulated, polarizable material amidst inflamed and necrotic lung parenchyma in three cases [Figure - 7]. Interestingly, acute renal failure in two patients was due to oxalate crystals plugging the renal tubules.




 :: Discussion Top




The ubiquity of the fungus Aspergillus is a major factor in designating our planet as ′our mouldy earth′. The fungus Aspergillus was baptized by the priest and botanist Micheli in 1729 since it bore resemblance to the perforated globe used for sprinkling holy water.[5] But the effect of the fungus is far from holy. Although the fungus can colonize any organ, the lungs are the most commonly affected. Depending on the host immunity, lung structure and degree of inoculum, pulmonary aspergillosis is classified into three types; Allergic, with a characteristic hypersensitivity reaction to the fungal elements, Saprophytic in which there is fungal colonisation of airways or parenchyma (′Fungal ball′ formation), devoid of destruction of viable tissue, or Invasive where the fungus evokes necrotizing suppurative or non-suppurative parenchymal lesions.[1],[6],[7],[8]



Invasive aspergillosis has acquired great importance as a cause of much morbidity and mortality in immunocompromised or immunosuppressed patients.[1] Though there are probably about 180 species of Aspergillus, only a handful cause human disease, especially A. fumigatus, rarely A. niger and a few others. A diagnosis of IPA requires repeated isolation of the fungus from the airways with appropriate clinical or radiological features and/or positive tissue diagnosis. These are identified as regular slender, septate hyphae that branch dichotomously at an angle of 45 degrees, a pattern closely mimicked by other genera like Pseudoallescheria or Fusarium.[1] In our study, since the organisms were not cultured in any, we have presumed Aspergillus aetiology in all on the basis of mere morphology.



Impairment of host defence, either overt or covert, is essential for the development of IPA. Central to this is an impairment or deficiency of phagocyte function (granulocytes or tissue macrophages).[9] Hence patients with haematological disorders like acute leukaemias and aplastic anaemias are particularly prone to this complication.[10] Patients with non-haematological malignancies[11] or with organ transplantation[5] are also similarly afflicted. In the present series, we had three cases of pancytopenia. Surprisingly, none of the 81 cases of leukaemia or lymphoma encountered at autopsy had evidence of pulmonary aspergillosis. There were four cases with renal transplant.



The main predisposing factors in this study were prolonged antibiotic therapy, steroid therapy and alteration of pulmonary architecture or local immunity such as bronchial asthma, tuberculosis or chronic obstructive pulmonary disease. Such factors have been implicated in the causation of semi-invasive or chronic necrotising aspergillosis, initially described in the 1980s.[12],[13] This results in a cavitary lesion, especially in the upper lobes, with surrounding acute or chronic inflammation with or without fungal ball formation.[14] This variety supports the concept that the allergic, saprophytic and invasive forms may represent a spectrum of disease dependent on lung structure and immune status.[12] All our cases had the morphology of the usual acute invasive form. Only one patient had disease restricted to the right upper lobe but did not have the aforementioned characteristics of the semi-invasive form. Aspergilloma were present in two cases with fibrocavitary tuberculosis, with subsequent invasion as occurs with the saprophytic variant.[1]



Diabetes mellitus, alcohol abuse, renal or hepatic failure which affect neutrophil proliferation, maturation, function and lifespan, and other immunological disorders are other predisposing factors.[1],[12],[13] These represented a small proportion in our patients. Despite a primary T cell dysfunction in HIV infection, these patients are prone to IPA, probably as a result of other common predisposing factors.[15],[16] We have not come across any case of AIDS in our study. In general, autopsies are not performed in established cases of AIDS at our institution. Fungally contaminated aerosol due to defective disposal or environmental manipulation such as hospital reconstruction projects can lead to an outbreak of IPA.[17],[18] Maximum number of cases were seen by us in 1996 (11 cases) but unrelated to the above mechanisms. Similarly, prolonged stay in intensive care units and / or mechanical ventilation has also been implicated.[19] Seven of our patients had such a history. Six other patients did not have any apparent predisposition, including to extreme exposure to Aspergillus spores, as occurs at times.[20],[21] On the whole, it appears that majority of patients in this autopsy series, were not greatly immunocompromised. Also, this rate of aspergillosis (0.19%) may not represent the true incidence in a general hospital setting, since all the fatal cases of IPA and the known HIV positive cases are not autopsied. Furthermore, fungal stains were not routinely performed in all cases of consolidation, abscesses or infarction and therefore gross disease was probably picked up but not the minor disease. Nevertheless, it is quite different from the autopsy series, where majority of the patients have had solid organ transplantation or haematological disorders, especially leukaemais.[2],[3],[4],[22]



Most patients had respiratory symptoms, clinical signs, laboratory and radiological features no different from bacterial pneumonias. Hence a diagnosis of IPA was not made clinically in any of these patients. A high index of suspicion is therefore very essential, especially in immune depleted cases. Fine needle aspiration cytology or biopsy can be done to demonstrate fungal hyphae destroying viable tissue.[23] Alternatively, galactomannan antigen or DNA detection may be adopted for early diagnosis and management.[24],[25] Many of these tests have been recently developed and if now employed would ensure high pick-up rate. However, difficulties arise when there are no respiratory symptoms as seen in 43 % of our patients.



IPA manifests as several distinct clinicopathological forms, namely acute bronchopneumonia, angioinvasive aspergillosis, acute tracheobronchitis, miliary aspergillosis and pleural aspergillosis.[1] Despite this classification into various morphologic subtypes, we found a combination of lesions in most. The commonest finding was the presence of multifocal consolidation, complicated by abscess formation. Central cavitation with shaggy walls and semisolid gray white contents was an additional feature. This occurred in 4-16%, caused by the separation of the infected portion from viable parenchyma.[11] Separation and dissolution occurs due to enzymes released from neutrophils or Aspergillus species.[11] The former plays a more important role as documented by Albeda et al [26] where cavitation coincided with recovery from neutropenia. This may at times aid in the radiological diagnosis of the disease [27],[28] with a characteristic crescent or halo sign. But in other cases, the appearance is no different from bacterial consolidations.[28] Later in the course of the disease, these cavities instigate formation of fungal balls.[29] We did not record any such phenomenon. Aspergilloma in this study occurred in tuberculous cavities.



Angioinvasion was the next common manifestation, and accompanied bronchopneumonia in 26. This produces bland thrombosis and/or vasculitis and subsequent infarction. The other variant of angioinvasion, target lesions, were present in seven. These are said to represent coagulative necroses of the lung due to enzymes or toxins elaborated by the fungi. Pure angioinvasive disease was seen in only one patient. Pleural thickening and fibrosis as noted in a few of the cases were most commonly due to tuberculosis. In the other cases, though there was an inflammatory exudate, fungal hyphae were not demonstrated. Aspergillous tracheobronchitis is a rare and often sole manifestation with pseudo-membranes partly or completely occluding the airway lumina.[30],[31],[32] This can involve the airways at all levels. We had five such cases, one of which had only acute bronchiolitis. There was no case of miliary aspergillosis. We came across an interesting case of granulomatous aspergillosis,[33] not well documented in literature. He was a 17-year-old male with a history of bronchial asthma (possibly allergic broncho-pulmonary aspergillosis) with blood and sputum eosinophilia. Non-caseating granulomata systematically destroyed the pleura and the pulmonary interstitium. This is an example of the allergic form paving the way for true invasive aspergillosis.



Certain Aspergillus species, particularly A. niger are associated with the production of oxalic acid, through tricarboxylic acid cycle. The oxalic acid so generated combines with the host-derived calcium to form birefringent calcium oxalate crystals. Thus demonstration of these crystals in tissue or fluid indicates some type of fungal infection.[34] Crystals were identified in three patients, two of whom developed acute renal failure following renal hyperoxalosis.



IPA is a devastating disease. Since the manifestations vary according to the immune status of the host and the underlying lung disease, the clinical and radiographic features vary.[35] Therefore, it should always be considered in the differential diagnosis of pneumonia, tuberculosis, lung abscess and bronchiectasis.[36] Despite early diagnosis, the disease is difficult to treat because of extensive pulmonary involvement and /or extra pulmonary dissemination. Twenty percent of patients had extra pulmonary involvement. Besides, coexistent infections that flourish in immunodeficient background, as seen in 30.7 % of patients in this study, add to the mortality and morbidity.




 :: Acknowledgements Top




The authors gratefully acknowledge the help rendered by Mr. Avinash Marathe, Artist, Department of Anatomy, Seth G. S. Medical College for the photography.

 
 :: References Top

1.Fraser RS. Pulmonary aspergillosis: pathologic and pathogenetic features. Pathol Annu 1993;12:231-77.   Back to cited text no. 1    
2.Vogeser M, Haas A, Aust D, Ruckdeschel G. Postmortem analysis of invasive aspergillosis in a tertiary care hospital. Eur J Clin Microbiol Infect Dis 1997;16:1-6.   Back to cited text no. 2  [PUBMED]  
3.Subira M, Martino R, Rovira M, Vazquez L, Serrano D, De La Camara R. Clinical applicability of the new EORTC/MSG classification for invasive pulmonary aspergillosis in patients with hematological malignancies and autopsy-confirmed invasive aspergillosis. Ann Hematol 2003;82:80-2.   Back to cited text no. 3  [PUBMED]  [FULLTEXT]
4.Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996;33:23-32.   Back to cited text no. 4  [PUBMED]  
5.Robinson LA, Reed EC, Galbraith TA, Alonso A, Moulton AL, Fleming WH. Pulmonary resection of invasive Aspergillus infections in immunocompromised patients. J Thorac Cardiovasc Surg 1995;109:1182-97.  Back to cited text no. 5    
6.Hinson KF, Moon AJ, Plummer NS. Bronchopulmonary aspergillosis: A review and a report of eight new cases. Thorax 1952;7:317-33.  Back to cited text no. 6  [PUBMED]  
7.Zimmerman RA, Miller WT. Pulmonary aspergillosis. Am J Surg Pathol 1970;109:505-17.  Back to cited text no. 7  [PUBMED]  
8.Finegold SM, Will D, Murray JF. Aspergillosis: A review and report of 12 cases. Am J Med 1959;27:463-82.  Back to cited text no. 8    
9.Diamond RD. Immune response to fungal infection. Rev Infect Dis 1989;11:S1600-4.  Back to cited text no. 9  [PUBMED]  
10.Yeghen T, Kibbler CC, Prentice HG, Berger LA, Wallesby RK, McWhinney PH, et al. Management of invasive pulmonary aspergillosis in hematology patients:a review of 87 consecutive cases at a single institution. Clin Infect Dis 2000;31:859-68.  Back to cited text no. 10  [PUBMED]  [FULLTEXT]
11.Pai U, Blinkhorn RJ Jr, Tomashefski JF Jr. Invasive cavitary pulmonary aspergillosis in patients with cancer:a clinicopathologic study. Hum Pathol 1994;25:293-303.  Back to cited text no. 11  [PUBMED]  
12.Gefter WB, Weingrad TR, Epstein DM, Ochs RH, Miller WT. ′Semi invasive′ pulmonary aspergillosis. A new look at the spectrum of Aspergillus infection of the lung. Radiology 1981;140:313-21.  Back to cited text no. 12  [PUBMED]  
13.Binder RE, Faling LJ, Pugatch RD, Mahasen C, Snider GL. Chronic necrotizing pulmonary aspergillosis: A distinct clinical entity. Medicine 1982;61:109-24.  Back to cited text no. 13    
14.Caras WE, Pluss JL. Chronic necrotizing pulmonary aspergillosis:Pathologic outcome after itraconazole therapy. Mayo Clin Proc 1996;71:25-30.  Back to cited text no. 14  [PUBMED]  
15.Nash G, Irvine R, Kerschmann RL, Herndier B. Pulmonary aspergillosis in acquired immune deficiency syndrome. Autopsy study of an emerging pulmonary complication of human immunodeficiency virus infection. Hum Pathol 1994;28:1268-75.  Back to cited text no. 15    
16.Miller WT Jr, Sais GJ, Frank I, Gefter WB, Aronchick JM, Miller WT. Pulmonary aspergillosis in patients with AIDS. Clinical and radiographic correlations. Chest 1994;105:37-44.  Back to cited text no. 16  [PUBMED]  
17.Opal SM, Asp AA, Cannady PB Jr, Morse JL, Burton LJ, Hammer PG. Efficacy of infection control measures during a nosocomial outbreak of disseminated aspergillosis associated with hospital construction. J Infect Dis 1986;153:634-7.  Back to cited text no. 17    
18.Anderson K, Morris G, Kennedy H, Croall J, Michie J, Richardson MD, et al. Aspergillosis in immunocompromised paediatric patients; associations with building hygiene, design and indoor air. Thorax 1996;51:256-61.  Back to cited text no. 18  [PUBMED]  
19.Bulpa PA, Dive AM, Garrino MG, Delos MA, Gonzalez MR, Evrand PA, et al. Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: Benefits of intensive care? Int Care Med 2001;27:59-67.  Back to cited text no. 19    
20.D′Silva H, Burke JF, Cho SY. Disseminated aspergillosis in a presumably immunocompetent host. J Am Med Assoc 1982;248:1495-7.  Back to cited text no. 20    
21.Karam GH, Griffin FM Jr. Invasive pulmonary aspergillosis in non immunocompromised, non neutropenic hosts. Rev Infect Dis 1986;8:357-63.   Back to cited text no. 21  [PUBMED]  
22.Vogeser M, Wanders A, Haas A, Ruckdeschel G. A four-year review of fatal Aspergillosis. Eur J Clin Microbiol Infect Dis 1999;18:42-5.   Back to cited text no. 22  [PUBMED]  [FULLTEXT]
23.Kim K, Lee MH, Kim J, Lee KS, Kim SM, Jung MP, et al. Importance of open lung biopsy in the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies. Am J Hematol. 2002;71:75-9.   Back to cited text no. 23    
24.Dupont B, Richardson M, Verweij PE, Meis JF. Invasive aspergillosis. Med Mycology 2000;38:215-24.  Back to cited text no. 24    
25.Stevens DA. Diagnosis of fungal infections:current status. J Antimicrob Chemother 2002;49:11-9.   Back to cited text no. 25  [PUBMED]  [FULLTEXT]
26.Albelda SM, Talbot GH, Gerson SL, Miller WT, Cassileth PA. Pulmonary cavitation and massive hemoptysis in invasive pulmonary aspergillosis. Influence of bone marrow recovery in patients with acute leukemia. Am Rev Respir Dis 1985;131:115-20.  Back to cited text no. 26  [PUBMED]  
27.Kim MJ, Lee KS, Kim J, Jung KJ, Lee HG, Kim TS. Crescent sign in invasive pulmonary aspergillosis: Frequency and related CT and clinical factors. J Comput Assist Tomo 2001;25:305-10.  Back to cited text no. 27    
28.Kami M, Kishi Y, Hamaki T, Kawabata M, Kashima T, Masumoto T, et al. The value of the chest computed tomography halo sign in the diagnosis of invasive pulmonary aspergillosis. An autopsy-based retrospective study of 48 patients. Mycoses 2002;45:287-94.   Back to cited text no. 28  [PUBMED]  
29.Kibbler CC, Milkins SR, Bhamra A, Spiteri MA, Noone P, Prentice HG. Apparent pulmonary mycetoma following invasive aspergillosis in neutropenic patients. Thorax 1988;43:108-12.  Back to cited text no. 29  [PUBMED]  
30.Young RC, Bennett JE Vogel CL, Carbonne PP, DeVita VT. Aspergillosis: The spectrum of the disease of 98 patients. Medicine (Baltimore) 1970;49:147-73.  Back to cited text no. 30    
31.Clarke A, Skelton J, Fraser R. Fungal tracheobronchitis. Report of 9 cases and review of literature. Medicine 1991;70:1-14.  Back to cited text no. 31    
32.Tazelaar HD, Baird Am, Mill M, Grimes MM, Schulmann LL, Smith CR. Bronchocentric mycosis occurring in transplant recipients. Chest 1989;96:92-5.  Back to cited text no. 32    
33.Addis B. Pulmonary mycotic disease. In: Hasleton PS, ed. Spencer′s pathology of the lung. 5th edn. New York McGraw Hill; 1996. p. 257-307.  Back to cited text no. 33    
34.Farley ML, Mabry L, Munoz LA, Diserens HW. Crystals occurring in pulmonary cytology specimens. Association with Aspergillus infection. Acta Cytol 1985;29:737-44.  Back to cited text no. 34  [PUBMED]  
35.Broderick LS, Conces DJ Jr, Tarver RD, Bergmann CA, Bisesi MA. Pulmonary aspergillosis: A spectrum of disease. Crit Rev Diag Imag 1996;37:491-531.  Back to cited text no. 35    
36.Kothari K, Singh V, Sharma R, Khandelwal R. Diagnostic dilemma:aspergillosis. J Assoc Physicians India 2000;48:445-7.  Back to cited text no. 36  [PUBMED]  


    Figures

[Figure - 1], [Figure - 2], [Figure - 3], [Figure - 4], [Figure - 5], [Figure - 6], [Figure - 7]

    Tables

[Table - 1], [Table - 2], [Table - 3]

This article has been cited by
1 Invasive aspergillosis in developing countries
Chakrabarti, A., Chatterjee, S.S., Das, A., Shivaprakash, M.R.
Medical Mycology. 2011; 49(suppl 1): s35-S47
[Pubmed]
2 Generalized lymphadenopathy secondary to an invasive fungal infection in an apparently healthy patient
Nourbakhsh, E., Goodman, S., Nash, S., Nugent, K.
American Journal of the Medical Sciences. 2010; 340(1): 84-88
[Pubmed]
3 Antifungal susceptibilities of aspergillus SPP. strains isolated from invasive aspergillosis cases | [İnvazi̇f aspergi̇llozlu olgulardan i̇zole edi̇len aspergillus SPP. suşlarinin anti̇fungal duyarliliklari]
Gürcan, Ş., Tlkveşli, M., Eryildiz, C., Evcl, C., Ener, B.
Mikrobiyoloji Bulteni. 2010; 44(2): 273-278
[Pubmed]
4 Aspergillus and aspergillus diseases | [Aspergillus et maladies aspergillaires]
Desoubeaux, G., Chandenier, J.
Feuillets de Biologie. 2010; 51(293): 53-63
[Pubmed]
5 Tracheobronchial manifestations of aspergillosis
Patel, N., Saleh, A., Raoof, S., Gudi, M., George, L., Prakash, U.B.S.
Journal of Bronchology. 2010; 17(1): 45-53
[Pubmed]
6 Invasive pulmonary aspergillosis in patients with antineutrophil cytoplasmic antibody associated vasculitis
Su, T., Li, H.-C., Chen, M., Gao, L., Zhou, F.-D., Wang, R.-G., Zhang, H., Zhao, M.-H.
Journal of Clinical Rheumatology. 2009; 15(8): 380-382
[Pubmed]
7 Conidiation color mutants of Aspergillus fumigatus are highly pathogenic to the heterologous insect host Galleria mellonella
Jackson, J.C., Higgins, L.A., Lin, X.
PLoS ONE. 2009; 4(1): art e4224
[Pubmed]
8 Pulmonary aspergillosis: Different diseases for the same pathogen
Dimopoulos, G., Karampela, I.
Clinical Pulmonary Medicine. 2009; 16(2): 68-73
[Pubmed]
9 Invasive pulmonary aspergillosis: 20 cases
Jiang, H., Zhao, B.-L., Shi, Y., Cao, E.-H., Song, Y., Zhang, G., Sun, W.
Chinese Journal of Infection and Chemotherapy. 2009; 9(4): 293-296
[Pubmed]
10 Invasive pulmonary aspergillosis, part 1: Diagnosis
Papanicolaou, G.A., White, D.A.
Journal of Respiratory Diseases. 2008; 29(10): 405-410
[Pubmed]
11 Overview of opportunistic fungal infections in India
Chakrabarti, A., Chatterjee, S.S., Shivaprakash, M.R.
Japanese Journal of Medical Mycology. 2008; 49(3): 165-172
[Pubmed]
12 Pathology of pulmonary aspergillomas
Shah, R., Vaideeswar, P., Pandit, S.
Indian Journal of Pathology and Microbiology. 2008; 51(3): 342-345
[Pubmed]
13 The multiple faces of Aspergillus fumigatus and its impact on humans
Dimitropoulos, C., Filippou, N.
Archives of Hellenic Medicine. 2008; 25(3): 295-307
[Pubmed]
14 Aspergillus spp. isolations from respiratory tract samples in Trakya University Hospital | [Trakya Üniversitesi Hastanesiænde solunum yolu örneklerinde Aspergillus spp. izolasyonlari]
Gürcan, S., Demir, M., Altiay, G., Tikveşli, M., Kiliç, H., Otkun, M.
Tuberkuloz ve Toraks. 2007; 55(2): 160-166
[Pubmed]
15 A case of resistant pulmonary and cerebral aspergillosis succesfully treated with voriconazole | [Vorikonazol ile tedavi edilen dirençli pulmoner ve serebral aspergilloz olgusu]
Uçan, E.S., Avkan Oǧuz, V., Güngör, Ö., Gülşen, A., Uǧural Sezak, N., Tertemiz, K.C., Ceylan, E., (...), Şanli, A.
Tuberkuloz ve Toraks. 2006; 54(1): 75-79
[Pubmed]
16 Targeted high lung concentrations of itraconazole using nebulized dispersions in a murine model
McConville JT, Overhoff KA, Sinswat P, et al.
PHARMACEUTICAL RESEARCH. 2006; 23 (5): 901-911
[Pubmed]
17 Fungal respiratory disease
Yao ZR, Liao WQ
CURRENT OPINION IN PULMONARY MEDICINE. 2006; 12 (3): 222-227
[Pubmed]
18 Evaluation of the contaminant organisms of humidifier reservoir water and investigation of the source of contamination in a university hospital in Turkey
Nakipoglu Y, Erturan Z, Buyukbaba-Boral O, et al.
AMERICAN JOURNAL OF INFECTION CONTROL. 2005; 33 (1): 62-63
[Pubmed]
19 Surgical resection for successful treatment of invasive pulmonary aspergillosis: Report of 3 cases
Metin KS, Ugurlu BS, Kabakci B, Sariosmanoglu NO, Hazan E, Oto O
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2005; 37 (9): 694-696
[Pubmed]
20 Invasive aspergillosis in patients with chronic obstructive pulmonary diseases
Muquim A, Dial S, Menzies D
Canadian Respiratory Journal. 2005; 12(4): 199-204
[Pubmed]



 

Top
Print this article  Email this article
Previous article Next article
Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow